The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease

  1. Dalmau, R.
  2. Cordero, A.
  3. Masana, L.
  4. Ruiz, E.
  5. Sicras-Mainar, A.
  6. González-Juanatey, J.R.
Zeitschrift:
European Heart Journal Open

ISSN: 2752-4191

Datum der Publikation: 2024

Ausgabe: 4

Nummer: 2

Art: Artikel

DOI: 10.1093/EHJOPEN/OEAE027 GOOGLE SCHOLAR lock_openOpen Access editor